Wednesday, May 7, 2025
PTC Therapeutics (PTCT) Q1 2025 Earnings Call
May 6, 2025. Vatiquinone (Friedreich's Ataxia): FDA review proceeding without AdCom; confirmatory evidence from long-term data compared to FA-COMS natural history registry showing a reported 50% slowing in disease progression over three years.
